Amebic liver abscess: An update.

IF 2.5 Q2 GASTROENTEROLOGY & HEPATOLOGY World Journal of Hepatology Pub Date : 2024-03-27 DOI:10.4254/wjh.v16.i3.316
Ramesh Kumar, Rishabh Patel, Rajeev Nayan Priyadarshi, Ruchika Narayan, Tanmoy Maji, Utpal Anand, Jinit R Soni
{"title":"Amebic liver abscess: An update.","authors":"Ramesh Kumar, Rishabh Patel, Rajeev Nayan Priyadarshi, Ruchika Narayan, Tanmoy Maji, Utpal Anand, Jinit R Soni","doi":"10.4254/wjh.v16.i3.316","DOIUrl":null,"url":null,"abstract":"<p><p>Amebic liver abscess (ALA) is still a common problem in the tropical world, where it affects over three-quarters of patients with liver abscess. It is caused by an anaerobic protozoan <i>Entamoeba hystolytica</i>, which primarily colonises the cecum. It is a non-suppurative infection of the liver consisting primarily of dead hepatocytes and cellular debris. People of the male gender, during their reproductive years, are most prone to ALA, and this appears to be due to a poorly mounted immune response linked to serum testosterone levels. ALA is more common in the right lobe of the liver, is strongly associated with alcohol consumption, and can heal without the need for drainage. While majority of ALA patients have an uncomplicated course, a number of complications have been described, including rupture into abdomino-thoracic structures, biliary fistula, vascular thrombosis, bilio-vascular compression, and secondary bacterial infection. Based on clinico-radiological findings, a classification system for ALA has emerged recently, which can assist clinicians in making treatment decisions. Recent research has revealed the role of venous thrombosis-related ischemia in the severity of ALA. Recent years have seen the development and refinement of newer molecular diagnostic techniques that can greatly aid in overcoming the diagnostic challenge in endemic area where serology-based tests have limited accuracy. Metronidazole has been the drug of choice for ALA patients for many years. However, concerns over the resistance and adverse effects necessitate the creation of new, safe, and potent antiamebic medications. Although the indication of the drainage of uncomplicated ALA has become more clear, high-quality randomised trials are still necessary for robust conclusions. Percutaneous drainage appears to be a viable option for patients with ruptured ALA and diffuse peritonitis, for whom surgery represents a significant risk of mortality. With regard to all of the aforementioned issues, this article intends to present an updated review of ALA.</p>","PeriodicalId":23687,"journal":{"name":"World Journal of Hepatology","volume":null,"pages":null},"PeriodicalIF":2.5000,"publicationDate":"2024-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10989314/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Hepatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4254/wjh.v16.i3.316","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Amebic liver abscess (ALA) is still a common problem in the tropical world, where it affects over three-quarters of patients with liver abscess. It is caused by an anaerobic protozoan Entamoeba hystolytica, which primarily colonises the cecum. It is a non-suppurative infection of the liver consisting primarily of dead hepatocytes and cellular debris. People of the male gender, during their reproductive years, are most prone to ALA, and this appears to be due to a poorly mounted immune response linked to serum testosterone levels. ALA is more common in the right lobe of the liver, is strongly associated with alcohol consumption, and can heal without the need for drainage. While majority of ALA patients have an uncomplicated course, a number of complications have been described, including rupture into abdomino-thoracic structures, biliary fistula, vascular thrombosis, bilio-vascular compression, and secondary bacterial infection. Based on clinico-radiological findings, a classification system for ALA has emerged recently, which can assist clinicians in making treatment decisions. Recent research has revealed the role of venous thrombosis-related ischemia in the severity of ALA. Recent years have seen the development and refinement of newer molecular diagnostic techniques that can greatly aid in overcoming the diagnostic challenge in endemic area where serology-based tests have limited accuracy. Metronidazole has been the drug of choice for ALA patients for many years. However, concerns over the resistance and adverse effects necessitate the creation of new, safe, and potent antiamebic medications. Although the indication of the drainage of uncomplicated ALA has become more clear, high-quality randomised trials are still necessary for robust conclusions. Percutaneous drainage appears to be a viable option for patients with ruptured ALA and diffuse peritonitis, for whom surgery represents a significant risk of mortality. With regard to all of the aforementioned issues, this article intends to present an updated review of ALA.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
阿米巴肝脓肿:最新进展。
阿米巴肝脓肿(ALA)仍是热带地区的常见病,超过四分之三的肝脓肿患者都会受到影响。它是由厌氧原生动物恩塔莫阿米巴原虫引起的,恩塔莫阿米巴原虫主要定植于盲肠。它是一种非化脓性肝脏感染,主要由死亡的肝细胞和细胞碎片组成。处于生育期的男性最容易感染 ALA,这似乎是由于与血清睾酮水平相关的免疫反应机制不完善所致。ALA 更常见于肝脏右叶,与饮酒密切相关,无需引流即可痊愈。虽然大多数 ALA 患者的病程并不复杂,但也有一些并发症,包括破裂进入腹胸结构、胆瘘、血管血栓形成、胆道血管受压和继发性细菌感染。根据临床放射学发现,最近出现了一种 ALA 分类系统,可帮助临床医生做出治疗决定。最近的研究发现,静脉血栓相关缺血对 ALA 的严重程度有影响。近年来,新的分子诊断技术不断发展和完善,在血清学检测准确性有限的地方病流行地区,这些技术可以极大地帮助克服诊断难题。多年来,甲硝唑一直是 ALA 患者的首选药物。然而,由于对耐药性和不良反应的担忧,有必要开发新的、安全且强效的抗阿米巴药物。虽然无并发症的 ALA 引流指征已越来越明确,但仍需进行高质量的随机试验才能得出可靠的结论。对于有 ALA 破裂和弥漫性腹膜炎的患者来说,经皮引流似乎是一个可行的选择,因为手术有很大的死亡风险。针对上述所有问题,本文将对 ALA 进行最新综述。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
World Journal of Hepatology
World Journal of Hepatology GASTROENTEROLOGY & HEPATOLOGY-
CiteScore
4.10
自引率
4.20%
发文量
172
期刊最新文献
Chronic hepatitis B: Prevent, diagnose, and treat before the point of no return. Complement activation targeted inhibitor C2-FH ameliorates acetaminophen-induced liver injury in mice. Hepatitis B surface antigen-negative but hepatitis B envelope antigen-positive false occult hepatitis B virus infection: A case report. Liver cell cancer surveillance practice in Nigeria: Pitfalls and future prospects. Pathogenesis and research progress of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1